Prediction of likelihood of cancer recurrence

Details for Australian Patent Application No. 2004283068 (hide)

Owner Genomic Health, Inc. NSABP Foundation, Inc.

Inventors Baker, Joffre B.; Paik, Soonmyung; Bryant, John L.; Shak, Steven

Agent Griffith Hack

Pub. Number AU-B-2004283068

PCT Pub. Number WO2005/039382

Priority 60/482,339 24.06.03 US

Filing date 17 June 2004

Wipo publication date 6 May 2005

Acceptance publication date 18 March 2010

International Classifications

C12N 15/00 (2006.01) Mutation or genetic engineering

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/039382 Priority application(s): WO2005/039382

27 April 2006 Change of Name(s) of Applicant(s), Section 104

  Genomic Health, Has no value - Entry Incomplete The name of the applicant has been changed to Genomic Health, Inc.

25 May 2006 Change of Name(s) of Applicant(s), Section 104

  Genomic Health, Inc. The name of the applicant has been changed to Genomic Health, Inc.; NSABP Foundation, Inc.

3 December 2009 Amendment Made

  The nature of the amendment is: Amend the priority details to add under INID (62) 2004205878; 2004213871

11 February 2010 Amendment Made

  The nature of the amendment is: Amend the priority details to delete under INID (62) 2004205787 and 2004213871

18 March 2010 Application Accepted

  Published as AU-B-2004283068

15 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283073-Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds

2004283067-Transdermal high and low molecular weight compounds